Rocket Pharmaceuticals Announces Participation at Upcoming Conferences

NEW YORK--(BUSINESS WIRE)---- $RCKT--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces participation at the following upcoming conferences: Citi's 15th Annual BioPharma Virtual Conference Gaurav Shah, M.D., President and CEO, is scheduled to participate in a fireside chat on Thursday, September 10, 2020, at 1:30 p.m. Eastern Time. Jonathan D. Schwartz, M.D., C